a financial conglomerate
Industry PharmaceuticalsOther
A.I.dvisor tells us that ORGO and ESPR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGO and ESPR's prices will move in lockstep.
Ticker / NAME | Correlation To ORGO | 1D Price Change % | ||
---|---|---|---|---|
ORGO | 100% | -5.21% | ||
ESPR - ORGO | 28% Poorly correlated | N/A | ||
ANIP - ORGO | 27% Poorly correlated | -1.13% | ||
AMPH - ORGO | 27% Poorly correlated | -3.61% | ||
AMRX - ORGO | 26% Poorly correlated | -1.96% | ||
VTRS - ORGO | 25% Poorly correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To ORGO | 1D Price Change % |
---|---|---|
ORGO | 100% | -5.21% |
regenerative medicine theme (2 stocks) | 81% Closely correlated | -3.48% |
banks theme (326 stocks) | 33% Poorly correlated | +0.11% |
lease theme (39 stocks) | 28% Poorly correlated | +1.06% |
financial conglomerate theme (35 stocks) | 27% Poorly correlated | +1.12% |
insurance theme (104 stocks) | 20% Poorly correlated | +0.24% |
More |